Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
99mtc mdp (1 trial)
fludeoxyglucose f-18 (1 trial)
nabilone (cesamet) (1 trial)
ethanol (1 trial)
heparin (liquaemin) (1 trial)
sodium citrate (1 trial)
Bone Neoplasms (Phase 3)
Fibromyalgia (Phase 2)
Myofascial Pain Syndromes (Phase 2)
Neoplasms (Phase 3)
Trials (4 total)
Trial APIs (6 total)